相关实验视频
Updated: Aug 2, 2026

08:50
Depletion and Reconstitution of Macrophages in Mice
Published on: August 1, 2012
40.6K
雷米马佐拉姆减轻了巨细胞中脂聚糖诱导的炎症反应
Nobuyuki Matsuura1,2,3, Yuka Sendai2,3, Minami Hasegawa1,2
1Department of Oral Medicine and Hospital Dentistry, Tokyo Dental College.
The Bulletin of Tokyo Dental College
|February 15, 2026
概括
雷米马佐拉姆 (Re) 降低了巨细胞中的炎症性细胞因子,而不会影响细胞形成. 它的抗炎作用独立于GABAA受体,这表明它具有新的治疗潜力.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 像米达佐拉姆这样的二类药物表现出抗炎性质.
- 雷马佐拉姆 (Re) 对巨细胞免疫反应的影响尚不清楚.
研究的目的:
- 为了研究Re对脂聚糖 (LPS) 刺激的巨细胞激活的作用.
- 为了确定Re的抗炎作用是否涉及GABAA受体信号传递.
主要方法:
- 使用硫糖醇诱导的小鼠腹巨细胞 (TGC巨细胞).
- 用LPS刺激的巨细胞,并用Re治疗,有或没有flumazenil.
- 评估了细胞因子生产 (TNF-α,IL-6),共刺激分子表达 (CD86,MHCII类) 和细胞能力.
主要成果:
- Re显著减弱了LPS诱导的TNF-α和IL-6的产生.
- 弗卢马泽尼尔没有影响Re对细胞因子产生的抑制作用,这表明GABAA独立的作用.
- Re降低了CD86和MHCII类表达,但没有影响巨细胞消化.
结论:
- 雷米马佐拉姆通过独立于GABAA的通路在巨细胞中具有抗炎性质.
- 通过减少促炎性细胞因子和辅助刺激分子表达来调节巨细胞激活.
- 维生素R保留了必不可少的先天性免疫功能,如细胞形成,这表明它具有良好的安全性.
更多相关视频
10:35Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation
Published on: December 26, 2017
8.7K
11:48Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes
Published on: May 31, 2018
12.1K
相关概念视频
Carbohydrate Metabolism
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Oral Hypoglycemic Agents: Biguanides and Glitazones
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood glucose levels...